Frederick W. Driscoll is CFO at Flexion Therapeutics Inc (FLXN). They have made 10 open-market trades across 6 companies since 2007, most recently 2021-11-19.
CIK 0001129890
6 open-market purchases totalling $201K since 2007, against 4 sales. Across 5 scored buys the stock is up 12.2% at ninety days, and 14.0 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 60% | 40% |
| Avg Move | +23.6% | +15.0% | +12.2% |
| Alpha | +24.0% | +14.3% | +14.0% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLRB | BUY | 2021-09-03 | 2021-09-07 | $1.04 | $20K | -3.8% | -18.6% | -38.6% |
| MEIP | SELL | 2021-02-23 | 2021-02-24 | $4.03 | $101K | -7.4% | -10.0% | -30.7% |
| NK | SELL | 2020-08-11 | 2020-08-13 | $10.22 | $1.2M | -13.8% | -11.1% | -13.5% |
| MEIP | BUY | 2019-12-19 | 2019-12-20 | $1.60 | $100K | +21.1% | +27.4% | -49.9% |
| FLXN | SELL | 2017-03-23 | 2017-03-24 | $23.00 | $69K | +2.6% | +2.5% | -21.2% |
| FLXN | SELL | 2017-02-28 | 2017-03-02 | $19.96 | $1.3M | -4.5% | +32.1% | -17.7% |
| FLXN | BUY | 2016-05-17 | 2016-05-18 | $9.87 | $25K | +70.5% | +29.8% | +73.3% |
| FLXN | BUY | 2016-05-16 | 2016-05-17 | $9.19 | $23K | +56.4% | +40.1% | +79.8% |
| NVAX | BUY | 2011-08-09 | 2011-08-11 | $1.18 | $24K | -26.3% | -3.5% | -3.5% |
| GNLB | BUY | 2007-11-28 | 2007-11-28 | $1.45 | $10K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.